List of Bulk Drug Substances for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals or Antidotes for Food-Producing Animals; Request for Nominations

A feline-only veterinary hospital is opposing the removal of Ponazuril from the office stock list. They argue that the current commercial alternative is unsuitable for cats and that its removal hinders timely, cost-effective treatment for their patients.

The American Association of Feline Practitioners (AAFP) and the American Veterinary Medical Association (AVMA) are submitting nominations to add GC 376 and GS-441524 to the list of bulk drug substances for compounding office stock drugs. They argue that these substances are necessary for the urgent treatment of Feline Infectious Peritonitis (FIP) due to limited access to approved alternatives and the need for immediate treatment to prevent animal suffering.

Dr. Sonja R. Friedbauer, a veterinarian, argues against removing metronidazole from the list of bulk drug substances for compounding office stock. She states that the drug is essential for treating various conditions in small animals and that requiring compounding could be life-threatening for sick patients.

A veterinarian (or veterinary clinic staff) argues that keeping Metronidazole in office stock is essential for the immediate treatment of intestinal issues in animals. They request that the medication be included on the list to ensure patients can be treated promptly without waiting for prescriptions to be delivered.

A veterinary professional (implied by the mention of "feline practice" and "patients") argues that the new FDA regulations for in-stock medications will delay critical treatments for animals. They specifically highlight that the delay in accessing medications like metronidazole could be life-threatening for kittens with severe diarrhea.

An equine veterinarian is requesting that phenylbutazone be added to the list of bulk drug substances for compounding office stock. She argues that immediate access to various formulations of this medication is essential for the timely treatment of sick horses, especially since the commercial paste is currently unavailable.

A veterinarian (implied by the context of treating pets and hospitalized animals) argues against removing Metronidazole from the list of bulk drug substances for office stock. The commenter states that requiring individual prescriptions would delay necessary treatments for animals and is not in the animals' best interest.